Open Actively Recruiting

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

About

Brief Summary
Primary Purpose
Treatment
Study Type
Interventional
Phase
Phase 3

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

Exclusion Criteria:

Join this Trial

Share:
Study Stats
Protocol No.
23-000578
Category
Heart/Cardiovascular Diseases
Principal Investigator
Contact
Ladda Douangvila-Chhan
Location
  • UCLA Santa Monica
  • UCLA Westwood
For Providers
NCT No.
NCT05754957
For detailed technical eligibility, visit ClinicalTrials.gov.